Clinical and environmental samples from Portugal were screened for the presence of Aspergillus and the distributions of the species complexes were determined in order to understand how their distributions differ based on their source. Fifty-seven Aspergillus isolates from clinical samples were collected from 10 health institutions. Six species complexes were detected by internal transcribed spacer sequencing; Fumigati, Flavi, and Nigri were found most frequently (50.9%, 21.0%, and 15.8%, respectively). β-tubulin and calmodulin sequencing resulted in seven cryptic species (A. awamorii, A. brasiliensis, A. fructus, A. lentulus, A. sydowii, A. tubingensis, Emericella echinulata) being identified among the 57 isolates. Thirty-nine isolates of Aspergillus were recovered from beach sand and poultry farms, 31 from swine farms, and 80 from hospital environments, for a total 189 isolates. Eleven species complexes were found in these 189 isolates, and those belonging to the Versicolores species complex were found most frequently (23.8%). There was a significant association between the different environmental sources and distribution of the species complexes; the hospital environment had greater variability of species complexes than other environmental locations. A high prevalence of cryptic species within the Circumdati complex was detected in several environments; from the isolates analyzed, at least four cryptic species were identified, most of them growing at 37 o C. Because Aspergillus species complexes have different susceptibilities to antifungals, knowing the species-complex epidemiology for each setting, as well as the identification of cryptic species among the collected clinical isolates, is important. This Medical Mycology, 2014, Vol. 52, No. 5 may allow preventive and corrective measures to be taken, which may result in decreased exposure to those organisms and a better prognosis.
Introduction
As ubiquitous organisms, Aspergillus spp. are easily cultured from air (both indoor and outdoor), water, soil, sand, and vegetation. Similarly, aspergilli can be present in hospital environments in unfiltered air, ventilation systems, contaminated dust, water, food, and ornamental plants [1] . The various species of Aspergillus produce large numbers of small conidia that become airborne and can be inhaled easily; they then colonize the upper or lower airways [2, 3] . These conidia often remain in the air for prolonged periods due to their small size. Several nosocomial outbreaks have been attributed to environmental contamination [4, 5] . Diseases caused by Aspergillus spp. are diverse and include mycotoxicosis, allergy, and invasive infections. Invasive infections depend on the interplay between host susceptibility and environmental exposure to the conidia. There is limited invasion by aspergilli in immunocompetent individuals; however, large numbers of Aspergillus conidia are found in occupational environments such as agriculture, wood, and food industries (as poultry and swine) and in waste handling [6] . Airborne Aspergillus species have been linked closely with exacerbation of asthma and other allergic respiratory diseases.
Particles approximately 1-4 μm in diameter are deposited in the lower respiratory tract. Aspergillus fumigatus conidia are small enough to traverse the terminal respiratory airways and reach the pulmonary alveoli, whereas the larger conidia of some other Aspergillus species (eg, A. flavus and A. niger) tend to be deposited in the paranasal sinuses and upper airways [7] .
More than 250 species of Aspergillus have been described [8] . These are organized into subgenera and sections, or species complexes, based on morphological, metabolical, and molecular characteristics [2] . Comparative sequence analyses of the internal transcribed spacer (ITS) regions, specifically the ITS1 and ITS2 noncoding regions flanking the 5.8S rDNA, are appropriate loci for identification of Aspergillus isolates to the species-complex level [9] . Species identification of an unknown isolate of Aspergillus may be important given that different species show varying susceptibilities to multiple antifungal drugs [9, 10] . Recently, invasive pulmonary aspergillosis due to cryptic species within the common species-complex groups has been reported [11] .
Our main goals were to characterize species of Aspergillus collected from environmental and clinical sources in order to understand differences among sources and to gain an understanding of which species come from specific environmental settings and may be involved in infections and airway sensitization.
Materials and methods

Sample collection and laboratory processing
Clinical isolates. Fifty-seven clinical isolates of Aspergillus were collected from different patient samples from 10 healthcare institutions ( Fig. 1) between February 2011 and October 2012. To check the colony purity and observe colonial morphology, all isolates were plated for growth as single colonies on malt extract agar (MEA; 2%), with chloramphenicol (0.05 g/L).
Environmental isolates
Sand samples. Beach sand was collected from the 22 sampling sites shown in Fig. 1 and processed, as described previously [12] . In brief, samples of sand (40 gr) from different beaches were collected and put into sterile plastic containers. Sterilized distilled water (40 mL) was added to each sample and agitated for 30 min; 0.2 mL of this suspension was spread onto MEA in Petri dishes and incubated for 5-7 days at 27 o C.
Air, surface, and litter samples from poultry and swine
The locations of the seven poultry and seven swine farms where sampling was done are shown in Figure 1 . Collection and processing were performed as previously described [13, 14] . In brief, air samples from poultry and swine farms were collected at a height of 1 m, using an air sampler (Millipore, Billerica, MA, USA) with a velocity air rate of 140 L/min. The sampled air (25-50 m 3 ) was directly impacted onto MEA. Samples from indoor hard surfaces were collected by swabbing, using a cotton swab premoistened with sterile saline solution and a 10 cm × 10 cm square stencil, according to the International Standard ISO 18593 [15] . The sample swabs were then streaked onto MEA. Twenty-one litter (bedding) samples collected from seven poultry farms were placed into sterilized bags. Each litter sample (10 g) was suspended in 100 ml of sterilized distilled water and processed in the same way as the sand samples. All samples were incubated at 27 o C for 5-7 days.
Air and surface samples from hospital environment
This study was performed in a central hospital of Lisbon, Portugal (Fig. 1) ; the results correspond to four sampling collections (one sampling in each season: April 2012, September 2012, December 2012, and February 2013). The bone marrow transplant and hematology-oncology wards, as well as the intensive care unit (ICU), were selected as sampling sites since they include higher-risk patients. The bone marrow transplant unit includes eight isolation rooms with high-efficiency particulate absorption (HEPA)-filtered supply air, a male and a female multibed room, a meal room, and three bathrooms. The hematology-oncology ward is comprised of nine multibed rooms, two single rooms, and two bathrooms. The infectious diseases ICU is composed of five single rooms.
A total of 101 air samples and 99 surface samples were analyzed. Sampled surfaces included doorknobs, bedside tables, water taps, windows, and air conditioning grills. Surface and air sample collection was performed as described previously, except in the volume of air collected (500 L in this case) [16, 17] .
Morphological identification of the collected Aspergillus isolates
After plate incubation and colony isolation, slide mounts were made using tease mount or Scotch tape mount and lactophenol cotton blue mount procedures. The slides were examined microscopically for preliminary identifications. Morphological identification was done using macro-and microscopic characteristics as described previously [18] .
Molecular analysis
DNA was extracted using the High Pure PCR Template Preparation Kit (Roche Diagnostics Corp., Indianapolis, IN, USA), according to the manufacturer's instructions. The universal fungal primers ITS1 and ITS4 were used to amplify DNA from all isolates of Aspergillus, as described previously [19] . PCR products were analyzed by electrophoresis through 2% agarose gels. The resultant PCR amplicons were purified using the ExoSAP-IT enzyme system (USB Corporation, Cleveland, OH, USA), according to the manufacturer's instructions.
Sequencing of both strands was performed with the BigDye terminator v 1.1 cycle sequencing kit (Applied Biosystems) in the thermal cycler using the same primers as were used in the PCR amplification in ITS (ITS1 and ITS4) or calmodulin (cmd5 and cmd6) sequencing. For both regions, the conditions were as follows: an initial denaturation at 96 o C for For β-tubulin sequencing, another set of primers (Btub1 and Btub4) was used [23] . The amplification was done under the following conditions: an initial denaturation at 94 o C for 3 min, followed by 25 cycles of 96 o C for 10 s, 50 o C for 5 s, and 52 o C for 4 min, followed by one cycle of 60 o C for 5 min. The resultant nucleotide sequences were edited using the program Chromas Lite v 2.01 and aligned with the program CLUSTALX v 2.1 [24] . The sequences obtained were compared with sequences deposited in the GenBank (Bethesda, MD, USA) and CBS-KNAW Fungal Biodiversity Centre (Utrecht, the Netherlands) databases. The ITS sequences were used to identify isolates to the species-complex level, and the partial β-tubulin and calmodulin sequences were used to identify to the species level.
Statistical analysis
The [25] . The Cramer V coefficient was used to determine the intensity of the relationship between the tested variables [25] . Two-sided P values from tests were used to summarize the comparability and a 5% significance level was set. SPSS v 15.0 for Windows was used to perform the statistical analysis [26] .
Results
Screening of clinical isolates of Aspergillus for species-complex distribution
Clinical isolates of Aspergillus were screened to determine which, if any, cryptic species of Aspergillus were involved in patient infection. Clinical isolates from patient samples were collected from 10 institutions for 1 year. These isolates were identified on the basis of microscopic morphology and through the use of molecular tools (ITS, β-tubulin, and calmodulin gene sequencing; Table 1 ). A total of 57 Aspergillus isolates were collected. Three misidentifications at the species-complex level (based on morphology) were resolved by ITS sequencing (isolates 12-59, 12-60, and INSA9; Table 1 ). Furthermore, isolates 12-47 and INSA7 were identified morphologically only to the genus level (Aspergillus sp.), but both were classified as belonging to the Versicolores complex by molecular methodologies. Among the clinical isolates, six species complexes were detected by ITS sequencing and were distributed as follows: Fumigati (29 isolates; 50.9%), Flavi (12 isolates; 21.0%), Nigri (9 isolates; 15.8%), Terrei (3 isolates; 5.3%), Nidulantes (2 isolates; 3.6%), and Versicolores (2 isolates; 3.6%; Table 1 ). The frequency of the different species complexes was significantly different among Isolates from the Fumigati complex were the most prevalent in respiratory samples (ie, bronchial secretions, bronchoalveolar lavage, and sputum), with 20 isolates from 37 samples (54.1%) compared with isolates belonging to the Flavi (7 isolates; 18.7%) or Nigri (5 isolates; 13.9%) complexes. In addition, all three isolates belonging to the Terrei complex were from respiratory specimens. The remaining two isolates from respiratory specimens belonged to the Versicolores complex (Table 1) Table 1 ).
Distribution of Aspergillus species complexes in the environment
Because the environment represents the source of the isolates involved in patient infection, clinical and environmental samples were compared for the presence of different Aspergillus complexes. Samples from different environmental sources were screened for the presence of Aspergillus and the distribution of the different species complexes was determined. Four distinct environments were studied and analyzed in order to determine which Aspergillus complexes were present in each setting (Table 2) . Thirty-nine isolates of Aspergillus were recovered from beach sand, 39 from poultry farms, 31 from swine farms, and 80 from hospital environments, for a total 189 isolates. Of the samples collected from sand beaches, seven Aspergillus complexes were found; isolates belonging to the Fumigati complex were the most frequent (n = 10; 25.6%), followed by Circumdati and Nigri (each n = 9; 23.1%; Table 2 ). Isolates recovered from poultry farms were classified into eight complexes; the most representatives were in the Flavi (n = 15; 38.5%), Fumigati (n = 8; 20.5%), and Versicolores (n = 8; 20.5%) complexes (Table 2 ). For the isolates recovered from swine farms, the most frequently found were distributed among the Versicolores (n = 7; 22.6%), Flavi (n = 7; 22.6%), and Fumigati (n = 4; 12.9%) complexes (Table 2) . Isolates from the hospital environment showed a prevalence of those belonging to Versicolores (n = 26; 32.5%), Nigri (n = 12; 15.0%), Flavi (n = 11; 13.7%), and Circumdati (n = 6; 7.5%) complexes ( Table 3 ). A significant association was found among the different environmental sources and the distribution of several species complexes (P < 0.001), with the hospital environment having a greater variability of species complexes than other environmental locations.
In addition, there was a significant difference (P < 0.001) between clinical and environmental groups in Because of the large number of isolates from the Circumdati complex, especially found in the hospital environment, we performed more detailed studies of those isolates. These results showed their ability to grow at 37 o C and also the high prevalence of cryptic species within that complex (Table 4) . From the isolates analyzed, at least four cryptic species from A. ochraceus were detected (A. insulicola, A. ostianus, A. sclerotium, and A. westerdijkiae; Table 4 ). The hospital environment
Because the hospital environment represents a major concern as a source for the acquisition of Aspergillus infection, isolates were collected from a hospital's air and surfaces during four sampling periods (one sampling in each season; Table 5 ). Twenty-three (28.8%) isolates of Aspergillus were collected in spring, 18 (22.5%) in summer, 23 (28.8%) in autumn, and 16 (20.0%) in winter. A significant association (P = 0.001) was found between the season and the Aspergillus complexes isolated. Winter was the season with the lowest frequency of any of the species complex under study, whereas spring and summer had a larger number of species complexes detected. The Versicolores complex was the only one recovered in each of the four sampling periods, ranging from 2 to 28 cfu/m 3 of air (hematology ward);
Candidi and Usti complexes were detected only in winter and summer, respectively (Table 5) . Thirty-five isolates of Aspergillus were collected from wards with hematological patients (bone marrow transplant and hematology-oncology ward), predominantly from the air (in 77.1% of the isolates; Table 6 ).
In the bone marrow transplant ward, which is protected by HEPA filtration of the supply air, only five isolates of Aspergillus were detected, all from the air and most of them (four of five) during the autumn. The high efficiency in avoiding Aspergillus contamination by the use of HEPA filters in this ward is confirmed by the significant difference (P = 0.0058) in the number of isolates recovered from the different hospital wards. The isolates collected from the bone marrow ward belonged to the complexes Fumigati, Terrei, and Versicolores. With respect to the ICU, 15 isolates were recovered, with most obtained from surface samples (73.3% of the isolates; Table 6 ). A majority of these isolates belonged to the Flavi complex. For all units sampled, mixed contamination with isolates belonging to more than one Aspergillus species complex was detected in 21 air and 6 surface samples.
Discussion
This study presents an overview of the epidemiology of Aspergillus from clinical and environmental sources particularly relevant to Portugal and was designed to characterize the isolates identified morphologically as Aspergillus.
We performed a comparative sequence-based identification method using the ribosomal internal transcribed spacer region for identification to the species-complex level, followed by sequence of the β-tubulin and calmodulin genes for identification of the clinical isolates to the species level [27, 28] . Good agreement (97.6% overall) was found between morphological identification and sequence-based methods using the ITS regions to identify Aspergillus to the speciescomplex level. By morphology only, 5.3% clinical (3 of 57) and 1.6% environmental (3 of 189) isolates were misidentified at the species-complex level. Six environmental and two clinical isolates identified by morphology only as Aspergillus spp. were further sequenced, and the species complex was determined.
Various species complexes were detected, and differences in the biodiversity of Aspergillus species complexes from clinical sources and environmental settings were found. According to Klich [2] , the most frequently isolated Aspergillus species complexes in the clinical setting are the complexes Fumigati, Flavi, Nigri, and Terrei; these species complexes are also the most frequently isolated from the environment. In the present study, the A. fumigatus (ie, Fumigati) complex was the predominant etiological agent recovered from clinical samples, with organisms from the Flavi and Nigri complexes the next most common. These results are concordant with what was observed by others [27, 29, 30] . Within the Fumigati complex, only one clinical isolate in our study was found to be a sibling (cryptic) species of A. fumigatus (A. lentulus). This species has been described as being less susceptible to several antifungal drugs [10, 31] . In addition to our findings, several other cryptic species have been found in clinical isolates, namely, A. fumigatiaffinis, A. viridinutans, Neosartorya hiratsukae, N. pseudofischeri, and N. udagawae [23, 27, 32, 33] . Emericella echinulata (Nidulantes complex), previously E. nidulans var. echinulata, was isolated from one patient in our study. This species also has been described as an etiological agent of invasive aspergillosis [34] .
Seven clinical isolates belonging to the Nigri complex were identified as A. awamorii, A. brasiliensis, or A. tubingensis. Species such as A. awamori and A. tubingensis have been found among clinical isolates previously identified as A. niger [32] [33] [34] [35] . Howard et al. [35] observed that of 50 clinical isolates belonging to the Nigri complex, 26 (52%) were resistant to itraconazole. Itraconazole resistance was found for 36% of the isolates identified as A. awamori, 90% of those identified as A. tubingensis, 33% as A. niger, 100% as A. acidus, and 67% as an unknown group. To our knowledge, only one report on the involvement of A. brasiliensis in a human infection (keratitis) has been published [36] . This species also was found in the air at a poultry farm.
Aspergillus fructus and A. sydowii, sibling species from the Versicolores complex, were isolated from bronchoalveolar lavage samples taken from two patients. Aspergillus sydowii is recognized as a cause of infection, whereas A. fructus has not been reported to cause infection. Recently, Jurjević et al. [37] identified A. fructus, and an additional eight new species of fungi related to A. versicolor, based on multilocus DNA sequence phylogenies. Reports of these new species isolated from clinical samples have not yet been published. Our A. fructus isolate was collected from a patient suspected to have allergic bronchopulmonary aspergillosis. This isolate could be a respiratory tract colonizer, but we cannot exclude the possibility of it representing a new agent of infection.
Aspergilli, Candidi, Circumdati, and Usti complexes were detected only among the environmental isolates. This could be due to the lack of thermotolerance of some isolates or to the short time of incubation (ie, 3 days) of clinical specimens, thus preventing the appearance of slower-growing species. Species of Aspergillus may have a varied capability to colonize immunocompromised patients [30] .
Owing to an unexpected high prevalence, the 16 isolates belonging to Circumdati section were studied further and five species were identified, with A. insulicola and A. westerdijkiae being the most prevalent in beach sand and the hospital environment, respectively. Considering the prevalence of isolates of the Circumdati complex recovered from the hospital environment, their reduced susceptibility to several antifungals [38] [38] [39] [40] . In a prospective survey of aspergilli in airway samples, a patient colonized with A. ochraceus was found [31] . Therefore, the occurrence of these species in environments with many fungi also raises the possibility of occupational and patient exposure to these species. Some of the isolates observed in the primary cultures were not screened by molecular methods. This was because we were unable to recover pure cultures from the environmental samples that had a highly diverse fungal composition, when fungal species that grew faster made it extremely difficult to acquire pure colonies of the organism we wished to study. It is possible that this influenced, to a small degree, the overall molecular epidemiology found in each setting.
The most common environmental Aspergillus spp. found in this study were from the Versicolores, Flavi, Fumigati, and Nigri complexes. These data contrast with those of Guinea et al. [41] , who collected air and water samples from throughout the province of Madrid, Spain, in order to analyze the load of Aspergillus spores. They found A. fumigatus isolates most frequently.
Interestingly, in our study, the cryptic species of A. fumigatus, A. lentulus, and N. pseudofischeri were detected in samples from beaches. These species have been reported to be resistant in vitro to the azole antifungals [10, 23, 42] . To the best of our knowledge, little on environmental A. lentulus isolates has been published, and ours is the first report of cryptic species of A. fumigatus found in beach sand.
Similar to the results of Teixeira et al. [29] , who examined clinical and hospital environmental isolates of Aspergillus, we found that isolates of Aspergillus belonging to the Versicolores group were found mainly in environmental samples. This complex was isolated from all of the environmental settings we analyzed, including the hospital environment. In the latter, the Versicolores complex was followed in frequency by the Nigri, Flavi, and Circumdati complexes. In one study, A. niger was the most common species found in hospital air; A. fumigatus, A. flavus, and other Aspergillus spp. were the next most common [30] . Curiously, A. niger accounted for 56% of air isolates but only 17% of patient isolates, whereas A. fumigatus was rarely found in air but was the predominant isolate recovered from patients. In our study, the A. fumigatus complex was predominant in clinical samples (50.9%) but only the fourth most common in the hospital environment (8.8%). In a surveillance study of environmental fungal contamination in hospital operating rooms and hematological units, Faure et al. [43] observed that A. fumigatus was rarely isolated in the environment (3.7%). In accord with these results, in our study only seven isolates from the Fumigati complex were detected in the hospital environment (one from the bone marrow transplant unit, four from the hematology-oncology unit, and two from ICUs). In contrast, in a prospective surveillance study, A. fumigatus was the most common species found in hospital air (73.5%) [44] . In the ICU, we showed a prevalence of isolates from the Flavi group that was similar to the prevalence found in other studies that focused on fungal epidemiology in ICUs [45, 46] . Prior studies have also found hospital water isolates to have similar distribution as indoor and outdoor air [47] .
In general, the absolute number of Aspergillus isolates collected in the hospital environment did not differ among sampling periods. This is in accord with Leenders et al. [48] , who found seasonal variation in the number of conidia of nonpathogenic fungi found in the air within and outside the hospital, but minimal variation in the numbers of Aspergillus conidia. The Portuguese climate is characterized by dry, hot summers and relatively mild winters. The period from the end of May (spring and summer) until midSeptember is dry and rainfall occurs between November and February (autumn and winter). We found significant differences (P = 0.001) in the distribution of the species complexes based on collection period, and a larger number of species complexes were detected in the hospital environment during spring and summer. The latter result may be due to the occurrence of low precipitation and high temperatures. Others have found a higher proportion of A. fumigatus in autumn and winter [49] . In the present study, the same was observed for the Versicolores complex but not the Fumigati complex, which was recovered more frequently during the summer and autumn. This may be related to increased moisture (rainy season), falling leaves, and, consequently, increased organic matter available to support growth.
The present study of molecular identification of the Aspergillus species complexes found in clinical and environmental settings and of their prevalence and distribution in several Portuguese settings indicates a wide variety of Aspergillus species complexes and significant differences in their distribution. Using DNA sequencing, we detected several cryptic species and misidentifications based on morphology alone. Ongoing studies are being performed to sequence the β-tubulin and calmodulin genes of a larger number of isolates. Antifungal susceptibility tests will also lead to a better understanding of the susceptibility patterns of the collected isolates and the potential for drug resistance if encountered clinically. Since different species complexes show different pathogenic potential and different antifungal susceptibilities, our results may be helpful when determining preventive/protective measures to avoid specific exposure.
